Simply Wall St raises fair value for Kimball Electronics stock

Published on 10/07/2026 at 05:50 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Fiscal 2026 revenue reached USD 1.4 billion and margin was 4.60 percent. Simply Wall St gives Kimball Electronics stock USD 34.25 fair value.

KE, US49428J1097, Illustration mit AI erstellt.

Kimball Electronics stock (ISIN US49428J1097) is tied to a USD 34.25 fair value after Simply Wall St raised its estimate from USD 33.00 on October 6, 2026. The revised view puts medical manufacturing ahead of automotive weakness in the investment case.

Medical mix reaches 35 percent

Simply Wall St said on October 6, 2026 that Medical is moving toward 35 percent of total sales and cited adjusted operating income margin guidance of 4.40 percent to 4.70 percent. The same update lifted the revenue growth assumption from 1.04 percent to 5.97 percent, making mix improvement the central valuation driver.

Helvoet Polymer Technologies adds a medical contract development and manufacturing platform in Tilburg and Pune, while Kimball's Indianapolis facility expands its production capacity. The combination gives the medical segment a larger operating base, but facility ramp costs remain a direct margin consideration.

Fiscal 2026 restores cash discipline

In its September 30, 2026 proxy filing, the SEC filing reported fiscal 2026 revenue of USD 1.4 billion, an adjusted operating income margin of 4.60 percent, USD 72.0 million in operating cash flow and USD 117.0 million in borrowings. The filing also recorded USD 12.0 million returned through repurchases of 447,000 shares.

The latest full-year figures show the balance-sheet angle of the medical strategy. Cash generation supports facility investment and acquisition integration, while the reported borrowings level gives management more room to fund growth than in the prior operating cycle.

Fiscal 2027 guidance sets the test

Kimball Electronics' fiscal 2027 outlook calls for net sales of USD 1.535 billion to USD 1.560 billion, representing 7.00 percent to 9.00 percent growth over fiscal 2026, according to the Yahoo Finance transcript of the August 13, 2026 earnings call. Organic sales growth is expected at 3.00 percent to 5.00 percent, while Helvoet is expected to contribute USD 60.0 million.

The fourth-quarter comparison was mixed: sales of USD 371.6 million declined 2.00 percent year over year, while Medical sales of USD 109.0 million increased 1.00 percent. Adjusted operating income was USD 18.1 million, compared with USD 19.6 million in the prior-year quarter, so execution at the new facility remains the key counterweight to the stronger medical mix.

Prior close anchors euro view

The Lang & Schwarz prior close was EUR 25.50 on October 5, 2026. The primary Nasdaq listing last stood at USD 28.80 on October 6, 2026 at 4:00 p.m. ET, with a market capitalization of USD 692.7 million and a 52-week range of USD 21.01 to USD 32.00.

The further course of trading is shown by the continuously updated real-time quote of Kimball Electronics stock.